A miniature CRISPR-Cas10 enzyme confers immunity by an inverse signaling pathway
Authors:
- Erin E. DohertyEDErin E. Doherty
- Benjamin A. AdlerBABenjamin A. Adler
- Peter H. YoonPYPeter H. Yoon
- Kendall HsiehKHKendall Hsieh
- Kenneth LoiKLKenneth Loi
- Emily G. ArmbusterEAEmily G. Armbuster
- Arushi LahiriALArushi Lahiri
- Cydni S. BollingCBCydni S. Bolling
- Xander E. WilcoxXWXander E. Wilcox
- Joe PoglianoJPJoe Pogliano
Preprint
Abstract
Microbial and viral co-evolution has created immunity mechanisms involving oligonucleotide signaling that share mechanistic features with human anti-viral systems 1 . In these pathways, including CBASS and type III CRISPR systems in bacteria and cGAS-STING in humans, oligonucleotide synthesis occurs upon detection of virus or foreign genetic material in the cell, triggering the antiviral response 2–4 . In a surprising inversion of this process, we show here that the CRISPR-related enzyme mCpol synthesizes cyclic oligonucleotides constitutively as part of an active mechanism that maintains cell health. Cell-based experiments demonstrated that the absence or loss of mCpol-produced cyclic oligonucleotides triggers cell death, preventing spread of viruses that attempt immune evasion by depleting host cyclic nucleotides. Structural and mechanistic investigation revealed mCpol to be a di-adenylate cyclase whose product, c-di-AMP, prevents toxic oligomerization of the effector protein 2TMβ. Analysis of cells by fluorescence microscopy showed that lack of mCpol allows 2TMβ-mediated cell death due to inner membrane collapse. These findings unveil a powerful new defense strategy against virus-mediated immune suppression, expanding our understanding of oligonucleotides in cell health and disease. These results raise the possibility of similar protective roles for cyclic oligonucleotides in other organisms including humans.Keywords
This publication has 61 references indexed in Scilit:
- Genome integrity sensing by the broad-spectrum Hachiman antiphage defense complexCell, 2024
- Animal and bacterial viruses share conserved mechanisms of immune evasionCell, 2024
- Bacterial defense systems exhibit synergistic anti-phage activityCell Host & Microbe, 2024
- Cyclic CMP and cyclic UMP mediate bacterial immunity against phagesCell, 2021
- Mycobacterium tuberculosis CRISPR/Cas system Csm1 holds clues to the evolutionary relationship between DNA polymerase and cyclase activityInternational Journal of Biological Macromolecules, 2021
- Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-CasMolecular Cell, 2020
- HORMA Domain Proteins and a Trip13-like ATPase Regulate Bacterial cGAS-like Enzymes to Mediate Bacteriophage ImmunityMolecular Cell, 2020
- Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release PathMolecular Cell, 2019
- Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional InterferenceCell, 2019
- Crystal Structure of the Cmr2–Cmr3 Subcomplex in the CRISPR–Cas RNA Silencing Effector ComplexJournal of Molecular Biology, 2013